Sapient

Circulating Biomarker Discovery, Untargeted Biomarker Profiling

Sapient is an end-to-end biomarker discovery partner for pharmaceutical and biotechnology sponsors. Our platform combines advanced mass spectrometry technologies that assay >11,000 molecules per biosample, computational learning, and an expansive proprietary Human Biology Database of >300,000 individuals to discover circulating biomarkers at unprecedented speed and scale – and make them actionable in optimizing drug pipelines and advancing clinical development.

By identifying biomarkers of biological processes, disease progression, and drug responsiveness, we help elucidate the pathways involved in disease, drug delivery, and the individuals that will respond to a particular intervention, rapidly delivering actionable insights to align patients, disease biology, and specific therapies.

Services Offered

Rapid identification and validation of biomarkers of the:

Right Disease

• Disease mechanisms
• Target elucidation
• Early disease detection
• Disease progression

• Patient stratification
• Safety profiling
• Companion diagnostics
• Clinical trial enrichment

• Dosing strategies
• Timing of treatments
• Target engagement

 

Credentials

Sapient is CLIA certified.

Service Area

Sapient is located in San Diego, CA (USA) and services customers globally.